Drug profile · INN
verapamil hydrochloride
ISOPTIN
verapamil hydrochloride (ISOPTIN) is a voltage-gated l-type calcium channel blocker. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — verapamil hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
verapamil hydrochloride (ISOPTIN) is a voltage-gated l-type calcium channel blocker. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is verapamil hydrochloride?
verapamil hydrochloride (ISOPTIN) is a voltage-gated l-type calcium channel blocker. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for verapamil hydrochloride?
ISOPTIN is a marketed brand name for verapamil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of verapamil hydrochloride?
verapamil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.